Found: 102
Select item for more details and to access through your institution.
A Simulation of the Comparative Long-term Effectiveness of Liraglutide and Glimepiride Monotherapies in Patients with Type 2 Diabetes Mellitus.
- Published in:
- Pharmacotherapy, 2009, v. 29, n. 11, p. 1280, doi. 10.1592/phco.29.11.1280
- By:
- Publication type:
- Article
Rectilinear Bone Scanning Techniques.
- Published in:
- Journal of Nuclear Medicine Technology, 1977, v. 5, n. 1, p. 23
- By:
- Publication type:
- Article
Editorial Cycles and Continuity of Diabetes Care.
- Published in:
- 2022
- By:
- Publication type:
- editorial
Durable Effects of iGlarLixi Up to 52 Weeks in Type 2 Diabetes: The LixiLan-G Extension Study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A Lesson From 2020: Public Health Matters for Both COVID-19 and Diabetes.
- Published in:
- 2021
- By:
- Publication type:
- editorial
Switching to iGlarLixi Versus Continuing Daily or Weekly GLP-1 RA in Type 2 Diabetes Inadequately Controlled by GLP-1 RA and Oral Antihyperglycemic Therapy: The LixiLan-G Randomized Clinical Trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Editors' Expert Forum 2018: Managing Big Data for Diabetes Research and Care.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Big Topics for in 2018: Clinical Guidelines, Costs of Diabetes, and Information Technology.
- Published in:
- Diabetes Care, 2018, v. 41, n. 7, p. 1327, doi. 10.2337/dci18-0035
- By:
- Publication type:
- Article
Standardizing Clinically Meaningful Outcome Measures Beyond HbA<sub>1c</sub> for Type 1 Diabetes: A Consensus Report of the American Association of Clinical Endocrinologists, the American Association of Diabetes Educators, the American Diabetes Association, the Endocrine Society, JDRF International, The Leona M. and Harry B. Helmsley Charitable Trust, the Pediatric Endocrine Society, and the T1D Exchange.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Diabetes Care: "Taking It to the Limit One More Time".
- Published in:
- 2017
- By:
- Publication type:
- editorial
Diabetes Care: "Lagniappe" and "Seeing Is Believing"!
- Published in:
- 2016
- By:
- Publication type:
- editorial
Getting to the "Heart" of the Matter on Diabetic Cardiovascular Disease: "Thanks for the Memory".
- Published in:
- 2016
- By:
- Publication type:
- journal article
Building Momentum: Taking on the Real “Issues” of Diabetes Care!
- Published in:
- 2016
- By:
- Publication type:
- research
Status of Diabetes Care: New Challenges, New Concepts, New Measures--Focusing on.
- Published in:
- Diabetes Care, 2015, v. 38, n. 7, p. 1177, doi. 10.2337/dc15-0875
- By:
- Publication type:
- Article
Lixisenatide as add-on treatment among patients with different β-cell function levels as assessed by HOMA-β index.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Concomitant iGlarLixi and Sodium-Glucose Co-transporter-2 Inhibitor Therapy in Adults with Type 2 Diabetes: LixiLan-G Trial and Real-World Evidence Results.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 1, p. 205, doi. 10.1007/s13300-021-01180-1
- By:
- Publication type:
- Article
Glycemic Control Following GLP-1 RA or Basal Insulin Initiation in Real-World Practice: A Retrospective, Observational, Longitudinal Cohort Study.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 11, p. 2629, doi. 10.1007/s13300-020-00905-y
- By:
- Publication type:
- Article
Fixed-Ratio Combination of Insulin and GLP-1 RA in Patients with Longstanding Type 2 Diabetes: A Subanalysis of LixiLan-L.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 4, p. 1007, doi. 10.1007/s13300-020-00797-y
- By:
- Publication type:
- Article
Treatment Intensification in Type 2 Diabetes: A Real-World Study of 2-OAD Regimens, GLP-1 RAs, or Basal Insulin.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 1169, doi. 10.1007/s13300-018-0429-x
- By:
- Publication type:
- Article
Probability of Achieving Glycemic Control with Basal Insulin in Patients with Type 2 Diabetes in Real-World Practice in the USA.
- Published in:
- Diabetes Therapy, 2018, v. 9, n. 3, p. 1347, doi. 10.1007/s13300-018-0413-5
- By:
- Publication type:
- Article
From Randomized Controlled Trials to the Real World: Putting Evidence into Context.
- Published in:
- Clinician Reviews, 2018, p. S25
- By:
- Publication type:
- Article
Differential effects of glucagon-like peptide-1 receptor agonists on heart rate.
- Published in:
- Cardiovascular Diabetology, 2017, v. 16, p. 1, doi. 10.1186/s12933-016-0490-6
- By:
- Publication type:
- Article
Timed Bromocriptine-QR Therapy Reduces Progression of Cardiovascular Disease and Dysglycemia in Subjects with Well-Controlled Type 2 Diabetes Mellitus.
- Published in:
- Journal of Diabetes Research, 2015, v. 2015, p. 1, doi. 10.1155/2015/157698
- By:
- Publication type:
- Article
Efficacy of liraglutide added to sodium‐glucose cotransporter‐2 inhibitors in type 2 diabetes, stratified by baseline characteristics: Post‐hoc analysis of LIRA‐ADD2SGLT2i.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 10, p. 2234, doi. 10.1111/dom.14464
- By:
- Publication type:
- Article
Insulin glargine 300 units/mL for the treatment of individuals with type 2 diabetes in the real world: A review of the DELIVER programme.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 8, p. 1713, doi. 10.1111/dom.14405
- By:
- Publication type:
- Article
Switching to iGlarLixi versus continuation of a daily or weekly glucagon‐like peptide‐1 receptor agonist (GLP‐1 RA) in insufficiently controlled type 2 diabetes: A LixiLan‐G trial subgroup analysis by HbA1c and GLP‐1 RA use at screening
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 6, p. 1331, doi. 10.1111/dom.14345
- By:
- Publication type:
- Article
Insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi) compared with premix or addition of meal-time insulin to basal insulin in people with type 2 diabetes: A systematic review and Bayesian network meta-analysis.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2179, doi. 10.1111/dom.14148
- By:
- Publication type:
- Article
Efficacy and safety of iGlarLixi versus IDegLira in adults with type 2 diabetes inadequately controlled by glucagon-like peptide-1 receptor agonists: a systematic literature review and indirect treatment comparison.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 2170, doi. 10.1111/dom.14136
- By:
- Publication type:
- Article
Insulin glargine 300 U/mL versus first-generation basal insulin analogues in insulin-naïve adults with type 2 diabetes: 12-month outcomes of ACHIEVE Control, a prospective, randomized, pragmatic real-life clinical trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 11, p. 1995, doi. 10.1111/dom.14116
- By:
- Publication type:
- Article
Impact of disease duration and β‐cell reserve on the efficacy of switching to iGlarLixi in adults with type 2 diabetes on glucagon‐like peptide‐1 receptor agonist therapy: Exploratory analyses from the LixiLan‐G trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 9, p. 1567, doi. 10.1111/dom.14068
- By:
- Publication type:
- Article
Liraglutide as add‐on to sodium‐glucose co‐transporter‐2 inhibitors in patients with inadequately controlled type 2 diabetes: LIRA‐ADD2SGLT2i, a 26‐week, randomized, double‐blind, placebo‐controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 6, p. 929, doi. 10.1111/dom.13978
- By:
- Publication type:
- Article
Switching to insulin glargine 300 units/mL in real‐world older patients with type 2 diabetes (DELIVER 3).
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 11, p. 2384, doi. 10.1111/dom.13818
- By:
- Publication type:
- Article
Glycaemic goal attainment and hypoglycaemia outcomes in type 2 diabetes patients initiating insulin glargine 300 units/mL or 100 units/mL: Real‐world results from the DELIVER Naïve cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 7, p. 1596, doi. 10.1111/dom.13693
- By:
- Publication type:
- Article
Clinical outcomes in real‐world patients with type 2 diabetes switching from first‐ to second‐generation basal insulin analogues: Comparative effectiveness of insulin glargine 300 units/mL and insulin degludec in the DELIVER D+ cohort study
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 9, p. 2148, doi. 10.1111/dom.13345
- By:
- Publication type:
- Article
Long‐term sustainability of glycaemic achievements with second‐line antidiabetic therapies in patients with type 2 diabetes: A real‐world study.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 7, p. 1722, doi. 10.1111/dom.13288
- By:
- Publication type:
- Article
Real‐world evidence concerning clinical and economic outcomes of switching to insulin glargine 300 units/mL vs other basal insulins in patients with type 2 diabetes using basal insulin.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 5, p. 1293, doi. 10.1111/dom.13199
- By:
- Publication type:
- Article
Clinical correlates of hypoglycaemia over 4 years in people with type 2 diabetes starting insulin: An analysis from the CREDIT study.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 4, p. 921, doi. 10.1111/dom.13179
- By:
- Publication type:
- Article
Predictors of outcomes in patients with type 2 diabetes in the lixisenatide GetGoal clinical trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 2, p. 275, doi. 10.1111/dom.12815
- By:
- Publication type:
- Article
Factors Influencing Patient Acceptability of Diabetes Treatment Regimens.
- Published in:
- Clinical Diabetes, 2000, v. 18, n. 2, p. 61
- By:
- Publication type:
- Article
Linking improved glycemic control, quality of life, and economics: Evidence to support intuition.
- Published in:
- 1999
- By:
- Publication type:
- Journal Article
Medicine on the Web -- continued.
- Published in:
- Clinical Diabetes, 1999, v. 17, n. 4, p. 182
- By:
- Publication type:
- Article
Linking improved glycemic control, quality of life, and economics: Evidence to support intuition.
- Published in:
- Clinical Diabetes, 1999, v. 17, n. 4, p. 180
- By:
- Publication type:
- Article
The year 2000 computer bug: How to beat it.
- Published in:
- Clinical Diabetes, 1999, v. 17, n. 3, p. 121
- By:
- Publication type:
- Article
Impact of an electronic medical record on diabetes practice workflow.
- Published in:
- Clinical Diabetes, 1999, v. 17, n. 2, p. 89
- By:
- Publication type:
- Article
Electronic medical records in clinical practice.
- Published in:
- Clinical Diabetes, 1999, v. 17, n. 1, p. 43
- By:
- Publication type:
- Article
Web sites worth a visit.
- Published in:
- 1998
- By:
- Publication type:
- Journal Article
Web sites worth a visit.
- Published in:
- Clinical Diabetes, 1998, v. 16, n. 4, p. 191
- By:
- Publication type:
- Article
Automating diabetes care: The new millennium.
- Published in:
- Clinical Diabetes, 1998, v. 16, n. 3, p. 105
- By:
- Publication type:
- Article
Diabetes on the Web (continued).
- Published in:
- 1998
- By:
- Publication type:
- Editorial
Diabetes on the Web.
- Published in:
- Clinical Diabetes, 1998, v. 16, n. 1, p. 23
- By:
- Publication type:
- Article